Online Inquiry
Cat.#: ASSD-103
| Description | DAPI is a blue fluorescent DNA stain which is cell permeant at high concentrations. This is a ready made 1mg/mL staining solution. It is recommended to dilute this solution 1:1000 with your desired buffer for a 1µg/mL working concentration. 0.1µg/mL-10µg/mL is the typical working concentration used in most applications. DAPI also available. |
| Size | 1 mL, 5 mL, |
| Applications | The product is commonly used for cell imaging, cell counting, cell sorting (based on DNA content), apoptosis analysis, and HCA (high content analysis). |
| Chemical Name | 4',6-Diamidino-2-phenylindole dihydrochloride |
| Molecule Weight | 350.24 |
| Molecular formula | C16H15N5.2HCl |
| CAS Number | 28718-90-3 |
| Purity | >98% |
| Form | Pale yellow solution |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Important | When using this product for the first time, aliquot the DAPI ready-made solution and store at -20°C to avoid repeated freezing and thawing. Additionally, We strongly recommend storing this solution in the dark and away from light due to the compound's light sensitivity. |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-165 | FLUO 3-AM (AC165) | 1 mg | inquiry |
| ASSD-214 | 8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt (AC214) | 10 mg | inquiry |
| ASSD-184 | BTA-1 (AC184) | 10 mg | inquiry |
| ASSD-223 | Antifade Fluorescence Mounting Medium (aqueous) (AC223) | 10 mL | inquiry |
| ASSD-212 | 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) | 25 mg | inquiry |
| ASSD-140 | A2B covalent ligand (AC140) | 50 μg | inquiry |
| ASSD-127 | Fluorescent H3 antagonist [clobenpropit] (AC127) | 50 μg | inquiry |
| ASSD-197 | Sulforhodamine 101 acid chloride (AC197) | 10 mg, 25 mg | inquiry |
| ASSD-189 | 7-Hydroxycoumarin-3-carboxylic acid (AC189) | 100 mg | inquiry |
| ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.